GMO U.S. Core Equity III
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | Large Blend | | Fund Family: | GMO | | Net Assets: | 787.90M | | Year-to-Date Return: | -10.37% | | Yield: | 1.65% | | Morningstar Rating: |  | | Fund Inception Date: | 18-Sep-85 |
|
Sam Wilderman
Lead Manager since
30-Apr-05 | | | Wilderman is the director of U.S. equity management since 2005 and is responsible for all U.S. quantitative equities portfolio management at Grantham, Mayo, Van Otterloo & Co. LLC (GMO). Prior to this, he was a member of GMOs Emerging Markets Equity Group for nine years, focusing on research and portfolio management. Wilderman joined GMO in 1996. Wilderman holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $10,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks a total return greater than that of the S&P 500 index. The fund invests substantially all assets in the equities tied economically to the U.S. It intends to invest in the U.S. companies with larger capitalization to gain broad exposure to the U.S. equity market. The Manager defines "larger capitalizations" as capitalizations similar to the capitalizations of companies that issue stocks included in the S&P 500 index. |
| Last Dividend
(10-Jul-08):
| 0.05 | | Last Cap Gain
(21-Dec-07):
| 0.85 | | Annual Holdings Turnover
| 71.00% | | Average for Category:
| 71.30% |
|
| Expense | GMUEX | Category
Avg | | Total Expense Ratio: | 0.46%
| 1.11% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.21% | | Max Deferred Sales Load: | 0.00%
| 2.63% | | 3 Yr Expense Projection*: |
$152 | $577 | | 5 Yr Expense Projection*: |
$267 | $877 | | 10 Yr Expense Projection*: |
$602 | $1,739 |
|
|
5.11% Nasdaq 0.00%
Profile
